Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #8,841 to #8,890.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Noma medical therapy [261 bytes]
  2. (hist) Noma primary prevention [261 bytes]
  3. (hist) Noma physical examination [261 bytes]
  4. (hist) Noma other diagnostic studies [261 bytes]
  5. (hist) Noma natural history, complications and prognosis [261 bytes]
  6. (hist) Noma differential diagnosis [261 bytes]
  7. (hist) Noma pathophysiology [261 bytes]
  8. (hist) Oliguria epidemiology and demographics [261 bytes]
  9. (hist) CDI [261 bytes]
  10. (hist) Opioid (patient information) [261 bytes]
  11. (hist) Gallbladder polyp historical perspective [261 bytes]
  12. (hist) Rickets CT [261 bytes]
  13. (hist) Myxedema coma other diagnostic studies [261 bytes]
  14. (hist) Renal amyloidosis electrocardiogram [261 bytes]
  15. (hist) Chagas disease diagnostic study of choice [261 bytes]
  16. (hist) Bulk endotherms [262 bytes]
  17. (hist) HMG protein [262 bytes]
  18. (hist) Terpolymer [262 bytes]
  19. (hist) Reticuloendotheliosis [262 bytes]
  20. (hist) Bacillus pumilis [262 bytes]
  21. (hist) Roch-Amboise-Auguste Bébian [262 bytes]
  22. (hist) Thomas William Warnes [262 bytes]
  23. (hist) Fort Howard Veterans Hospital [262 bytes]
  24. (hist) Bcl-xL [262 bytes]
  25. (hist) C-Mos [262 bytes]
  26. (hist) Sanger's reagent [262 bytes]
  27. (hist) LAO Cranial [262 bytes]
  28. (hist) Core enzyme [262 bytes]
  29. (hist) Lansoprazole contraindications [262 bytes]
  30. (hist) Oral contraceptive formulations overdose [262 bytes]
  31. (hist) Lysergic acid diethylamide contraindications [262 bytes]
  32. (hist) Saidu Group Hospitals [262 bytes]
  33. (hist) Esophageal cyst [262 bytes]
  34. (hist) Porphyria future or investigational therapies [262 bytes]
  35. (hist) Albinism future or investigational therapies [262 bytes]
  36. (hist) Hypogonadism other diagnostic studies [262 bytes]
  37. (hist) Paget-Schroetter disease cost-effectiveness of therapy [262 bytes]
  38. (hist) Asbestosis laboratory tests [262 bytes]
  39. (hist) Caplans syndrome cost-effectiveness of therapy [262 bytes]
  40. (hist) Caplans syndrome future or investigational therapies [262 bytes]
  41. (hist) Caplans syndrome case study one [262 bytes]
  42. (hist) Portal hypertension cost-effectiveness of therapy [262 bytes]
  43. (hist) Patient improves [262 bytes]
  44. (hist) Carbenicillin indanyl sodium contraindications [262 bytes]
  45. (hist) Chronic pain case study one [262 bytes]
  46. (hist) Pesticide poisoning risk factors [262 bytes]
  47. (hist) Eosinophilia screening [262 bytes]
  48. (hist) C4 glomerulopathy risk factors [262 bytes]
  49. (hist) Secondary hyperaldosteronism overview [262 bytes]
  50. (hist) Spontaneous coronary artery dissection future or investigational therapies [262 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)